Back
Karyopharm Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
$0.64
Seasonality Move:
14.23%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight selling pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.68 | Sell |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 0.82 | Sell |
| 200-day SMA: | 0.96 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.79 | Sell |
| 200-day EMA: | 0.97 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 26.25 | Sell |
| Chaikin Money Flow: | 204002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.84) | Sell |
| Bollinger Bands (100): | (0.74 - 0.88) | Sell |
Karyopharm Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 0.64 while KPTI 8-day simple moving average is 0.68, which is a Sell signal.
-
The stock price of KPTI is 0.64 while Karyopharm Therapeutics 20-day SMA is 0.76, which makes it a Sell.
-
Karyopharm Therapeutics 50-day simple moving average is 0.82 while KPTI share price is 0.64, making it a Sell technically.
-
KPTI stock price is 0.64 and Karyopharm Therapeutics 200-day simple moving average is 0.96, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $0.64. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
80.8M
Price in USD:
0.64
Share Volume:
1.3M
Karyopharm Therapeutics 52-Week Range
52-Week High:
1.95
52-Week Low:
0.63
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 0.64 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 0.64 while KPTI 8-day exponential moving average is 0.68, which is a Sell signal.
-
The stock price of KPTI is 0.64 while Karyopharm Therapeutics 20-day EMA is 0.74, which makes it a Sell.
-
Karyopharm Therapeutics 50-day exponential moving average is 0.79 while KPTI share price is 0.64, making it a Sell technically.
-
KPTI stock price is 0.64 and Karyopharm Therapeutics 200-day simple moving average is 0.97, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 26.25, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (0.7 - 0.84), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (0.74 - 0.88), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.